HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement in hereditary hemorrhagic telangiectasia after treatment with the phosphoinositide 3-kinase inhibitor BKM120.

AuthorsUrban W Geisthoff, Ha-Long P Nguyen, Dagmar Hess
JournalAnnals of hematology (Ann Hematol) Vol. 93 Issue 4 Pg. 703-4 (Apr 2014) ISSN: 1432-0584 [Electronic] Germany
PMID23892886 (Publication Type: Case Reports, Letter)
Chemical References
  • Aminopyridines
  • Morpholines
  • NVP-BKM120
  • Phosphoinositide-3 Kinase Inhibitors
Topics
  • Aminopyridines (pharmacology, therapeutic use)
  • Female
  • Humans
  • Middle Aged
  • Morpholines (pharmacology, therapeutic use)
  • Phosphoinositide-3 Kinase Inhibitors
  • Telangiectasia, Hereditary Hemorrhagic (diagnosis, drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: